V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10305426 | 10039073 | 1.81 | 76.5 | Palliative (P) | null | 2018-11-27 | null | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101240699 |
| 10305558 | 10039075 | 1.78 | 63.4 | Curative (C) | 2017-11-13 | 2017-11-28 | CARBOPLATIN + GEMCITABINE | 02 | Y | CARBOPLATIN + GEMCITABINE | 101454856 |
| 10305583 | 10039076 | null | null | 03 | null | 2017-11-21 | null | null | N | TRIAL UNSPECIFIED | 101677598 |
| 10305641 | 10039077 | 1.56 | 72.7 | Curative (C) | 2018-05-25 | 2018-06-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100923558 |
| 10305662 | 10039078 | 1.64 | 101.05 | Neo-adjuvant (N) | null | 2020-01-10 | null | null | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101005963 |
| 10305744 | 10039080 | 1.79 | 69 | 03 | null | 2017-10-07 | null | null | N | CAPECITABINE + MITOMYCIN | 100782327 |
| 10305765 | 10039081 | null | 70.6 | Curative (C) | null | 2021-03-24 | null | null | null | VISMODEGIB | 100877972 |
| 10305784 | 10039082 | 1.77 | 71 | null | null | 2020-04-18 | null | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100622707 |
| 10305791 | 10039083 | null | 82.6 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-19 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 100995157 |
| 10305818 | 10039084 | 1.7 | 73.05 | Curative (C) | null | 2022-01-27 | null | null | null | CHLORAMBUCIL | 100479974 |
| 10305837 | 10039085 | 1.59 | 63.5 | Neo-adjuvant (N) | 2018-02-11 | 2018-02-19 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100293690 |
| 10305846 | 10039086 | null | 57.8 | null | null | 2021-09-21 | null | null | null | FLUOROURACIL + MITOMYCIN | 101288492 |
| 10305946 | 10039087 | 1.82 | 70.5 | null | 2019-01-30 | 2019-02-21 | Chlorambucil | 99 | null | CHLORAMBUCIL | 101296283 |
| 10306010 | 10039088 | 1.73 | 69.7 | Palliative (P) | 2019-01-19 | 2019-01-26 | Azacitidine | 02 | N | AZACITIDINE | 100400579 |
| 10306066 | 10039091 | 1.72 | 70.4 | Neo-adjuvant (N) | 2019-06-24 | 2019-08-13 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100262572 |
| 10306136 | 10039092 | 1.63 | 61 | Palliative (P) | null | 2019-09-03 | null | null | N | IMATINIB | 100423027 |
| 10306160 | 10039093 | 1.79 | 111.4 | Palliative (P) | null | 2019-12-23 | null | null | N | CAPECITABINE + MITOMYCIN | 100845876 |
| 10306230 | 10039095 | 1.72 | 70.4 | Curative (C) | null | 2019-01-05 | null | null | Y | CHLORAMBUCIL | 100107492 |
| 10306244 | 10039096 | null | 70 | Palliative (P) | null | 2017-01-26 | null | null | null | TRIAL UNSPECIFIED | 100626282 |
| 10306314 | 10039099 | 1.69 | 0 | Curative (C) | null | 2019-03-24 | null | null | Y | AZACITIDINE | 101045831 |
| 10306516 | 10039100 | 1.69 | 75.5 | Palliative (P) | null | 2018-04-26 | null | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100728862 |
| 10306520 | 10039101 | 1.78 | 75.35 | Palliative (P) | 2019-07-30 | 2019-08-06 | Cisplatin | 02 | null | CISPLATIN | 101684894 |
| 10306712 | 10039104 | 1.7 | 90 | Palliative (P) | null | 2018-05-29 | null | null | N | AZACITIDINE | 100561881 |
| 10306768 | 10039105 | 1.7 | 60.6 | Palliative (P) | null | 2020-07-30 | null | null | N | VISMODEGIB | 101790924 |
| 10306901 | 10039108 | 1.57 | 79.6 | null | null | 2018-08-29 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100532439 |
| 10306923 | 10039109 | 1.78 | 65.4 | Curative (C) | null | 2015-12-01 | null | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 101407948 |
| 10306976 | 10039110 | 1.59 | 66 | Disease modification (D) | null | 2019-05-10 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101278367 |
| 10306991 | 10039111 | 1.75 | 78.9 | Palliative (P) | null | 2020-04-22 | null | null | N | CISPLATIN | 100437345 |
| 10306999 | 10039112 | null | 60.8 | Curative (C) | null | 2019-10-18 | null | null | Y | TRIAL UNSPECIFIED | 101603536 |
| 10307028 | 10039113 | 1.69 | 84.3 | Curative (C) | 2021-04-26 | 2021-04-26 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101125918 |
| 10307054 | 10039114 | 1.72 | 54.7 | Curative (C) | null | 2019-11-09 | null | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100623143 |
| 10307110 | 10039115 | 1.6 | 0 | Neo-adjuvant (N) | 2016-12-01 | 2017-08-04 | Chlorambucil + Pred + Rituximab | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101048471 |
| 10307171 | 10039116 | 1.76 | 64.4 | null | 2019-07-13 | 2019-07-23 | Palbociclib | 02 | null | PALBOCICLIB | 100099533 |
| 10307180 | 10039117 | 1.81 | 95.1 | Palliative (P) | 2019-08-16 | 2019-08-16 | CISPLATIN + FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101638153 |
| 10307216 | 10039118 | 1.76 | 79 | 03 | 2019-08-28 | 2019-08-28 | POMALIDOMIDE | 02 | N | CLADRIBINE | 100073968 |
| 10307220 | 10039119 | 1.8 | 77.2 | Neo-adjuvant (N) | 2019-12-18 | 2019-12-26 | Avelumab | 02 | N | AVELUMAB | 100973123 |
| 10307327 | 10039121 | 1.7 | 75.9 | null | 2022-04-20 | 2022-05-12 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 101794889 |
| 10307420 | 10039122 | 1.78 | 60.3 | Palliative (P) | 2019-04-19 | 2019-04-19 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101405923 |
| 10307506 | 10039123 | 1.78 | 84.7 | null | 2021-03-14 | 2021-04-07 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100719557 |
| 10307515 | 10039124 | 1.66 | 65.6 | 03 | 2019-12-15 | 2020-01-03 | Cyclophosphamide + Dex + Rituximab | N | N | CVP R | 100495763 |
| 10307519 | 10039125 | null | 76 | Neo-adjuvant (N) | 2015-06-19 | 2015-06-25 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100416696 |
| 10307527 | 10039126 | 1.75 | 62.5 | null | 2022-01-07 | 2022-01-25 | Venetoclax | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100065748 |
| 10307604 | 10039128 | 1.53 | 62.55 | Palliative (P) | 2017-08-21 | 2017-08-21 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101507739 |
| 10307709 | 10039129 | 1.84 | 0 | Palliative (P) | 2018-11-15 | 2018-12-06 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100284774 |
| 10307775 | 10039131 | 1.58 | 80 | Neo-adjuvant (N) | 2020-09-25 | 2020-10-01 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101295323 |
| 10307802 | 10039132 | 1.64 | 95.5 | 03 | 2020-01-17 | 2020-01-23 | CHOP R | 02 | N | CHOP R | 100742166 |
| 10307832 | 10039133 | 1.76 | 96.6 | Neo-adjuvant (N) | 2018-05-23 | 2018-05-26 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100725688 |
| 10307860 | 10039134 | 1.64 | 63.6 | Neo-adjuvant (N) | 2018-08-22 | 2018-08-22 | Pazopanib | 02 | N | CVP R | 101169668 |
| 10307916 | 10039135 | 1.84 | 61.2 | Palliative (P) | 2019-08-11 | 2019-08-25 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101297722 |
| 10307929 | 10039136 | 1.81 | 67.6 | Palliative (P) | 2018-07-06 | 2018-07-07 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100890248 |